NCT01270178 Entecavir for Chronic Hepatitis B in Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation Therapy Status UNKNOWN Phase N/A
NCT01270165 Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis B Status UNKNOWN Phase PHASE3
NCT01267162 Long-term Study on Anti-HBV Effect of Tenofovir and Resistance Surveillance in Asian-American Adult Patients Status COMPLETED Phase N/A
NCT01266005 A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV Patients Status TERMINATED Phase PHASE4
NCT01264354 An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B Status COMPLETED Phase PHASE4
NCT01264133 A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B Status TERMINATED Phase PHASE4
NCT01264107 An Open Study to Evaluate the Sustained Effect in Patients Showing Virological Responses With Muscle-related Symptom of Chronic Hepatitis B Patients Who Received Clevudine Status COMPLETED Phase N/A
NCT01264094 A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period Status TERMINATED Phase PHASE4
NCT01260610 Randomized Controlled Study of Tenofovir Plus Telbivudine Versus Monotherapy With Either Drug in HBeAg Negative Chronic Hepatitis B Patients Status WITHDRAWN Phase NA
NCT01243281 Pegylated Interferon Alpha-2b Monotherapy Versus Combination With Entecavir in HBeAg-negative Chronic Hepatitis B Status UNKNOWN Phase NA
NCT01242787 Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B Status UNKNOWN Phase PHASE2
NCT01204827 Follow Up of Patients Chronic Hepatitis B (CHB) Treated With Sebivo Using the 13C Methacetin Breath Test Status WITHDRAWN Phase PHASE2/PHASE3
NCT01198860 Treatment on HBeAg Positive or HBeAg Negative in Chronic Hepatitis B Status APPROVED_FOR_MARKETING Phase N/A
NCT01172392 A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis B Status UNKNOWN Phase PHASE3
NCT01148576 Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B Patients Status UNKNOWN Phase PHASE4
NCT01143662 Efficacy and Safety of Ypeginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B Status COMPLETED Phase PHASE2
NCT01063036 Efficacy and Safety Study of Entecavir Plus Tenofovir in Patients With Chronic Hepatitis B Who Failed Previous Treatment Status COMPLETED Phase PHASE3
NCT01037166 Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine Therapy Status COMPLETED Phase PHASE2